OHI:NYE-Omega Healthcare Investors Inc. (USD)

EQUITY | REIT - Healthcare Facilities | New York Stock Exchange

Last Closing

USD 32.48

Change

+0.11 (+0.34)%

Market Cap

USD 5.58B

Volume

0.96M

Analyst Target

USD 33.06
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Omega Healthcare Investors Inc is a self-administered real estate investment trust. The Company is engaged in investing in income-producing healthcare facilities, including long-term care facilities located in the United States and United Kingdom.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-17 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-2.28 (-1.79%)

USD 79.04B
VTR Ventas Inc

-2.01 (-3.13%)

USD 26.84B
DOC Healthpeak Properties Inc

-0.22 (-0.99%)

USD 15.67B
CTRE CareTrust REIT Inc.

-0.39 (-1.26%)

USD 4.79B
NHI National Health Investors Inc

-1.81 (-2.13%)

USD 3.63B
AHR American Healthcare REIT, Inc.

+0.88 (+3.59%)

USD 3.26B
LTC LTC Properties Inc

-0.81 (-2.17%)

USD 1.64B
UHT Universal Health Realty Income..

-0.23 (-0.50%)

USD 0.64B
CHCT Community Healthcare Trust Inc

-0.51 (-2.94%)

USD 0.46B
GMRE-PA Global Medical REIT Inc

+0.17 (+0.68%)

USD 0.41B

ETFs Containing OHI

SRET Global X SuperDividend® .. 4.46 % 0.59 %

N/A

USD 0.23B
BKGI 4.30 % 0.00 %

N/A

N/A
KBWY Invesco KBW Premium Yield.. 3.89 % 0.35 %

+0.12 (+0%)

USD 0.24B
CUBS 3.05 % 0.00 %

N/A

N/A
FTIF First Trust Bloomberg Inf.. 2.24 % 0.00 %

+0.41 (+0%)

USD 1.22M
RIET Hoya Capital High Dividen.. 1.69 % 0.00 %

+0.03 (+0%)

USD 0.09B
JPME JPMorgan Diversified Retu.. 0.47 % 0.24 %

+1.13 (+0%)

USD 0.40B
BTAL AGFiQ U.S. Market Neutral.. 0.00 % 0.00 %

-0.40 (0%)

N/A
CVY Invesco Zacks Multi-Asset.. 0.00 % 0.65 %

+0.34 (+0%)

USD 0.12B
DIV Global X SuperDividend U... 0.00 % 0.46 %

N/A

USD 0.63B
FNDA Schwab Fundamental U.S. S.. 0.00 % 0.25 %

+1.04 (+0%)

USD 8.66B
GRI GRI Bio Inc. 0.00 % 0.55 %

-0.01 (0%)

N/A
GYLD Arrow ETF Trust 0.00 % 0.75 %

N/A

USD 0.02B
HIPS GraniteShares HIPS US Hig.. 0.00 % 0.70 %

+0.01 (+0%)

N/A
JKL 0.00 % 0.30 %

N/A

N/A
PSR Invesco Active U.S. Real .. 0.00 % 0.00 %

-0.04 (0%)

N/A
OLD 0.00 % 0.50 %

N/A

N/A
UXM.A:CA 0.00 % 1.49 %

N/A

N/A
PAMC Pacer Lunt MidCap Multi-F.. 0.00 % 0.00 %

+0.51 (+0%)

USD 0.06B
ISCV iShares Morningstar Small.. 0.00 % 0.00 %

+1.08 (+0%)

USD 0.43B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.94% 64% D 66% D+
Dividend Return 4.37% 93% A 90% A-
Total Return 10.31% 64% D 74% C
Trailing 12 Months  
Capital Gain 4.57% 57% F 50% F
Dividend Return 8.63% 93% A 89% A-
Total Return 13.20% 64% D 64% D
Trailing 5 Years  
Capital Gain -13.96% 75% C 32% F
Dividend Return 35.47% 92% A 90% A-
Total Return 21.51% 75% C 49% F
Average Annual (5 Year Horizon)  
Capital Gain -2.75% 57% F 26% F
Dividend Return 5.46% 79% B- 52% F
Total Return 8.21% 93% A 92% A
Risk Return Profile  
Volatility (Standard Deviation) 18.06% 64% D 57% F
Risk Adjusted Return 30.22% 79% B- 53% F
Market Capitalization 5.58B 80% B- 82% B

Key Financial Ratios

  Ratio vs. Industry/Classification (REIT - Healthcare Facilities) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.90 71% 24%
Price/Book Ratio 2.09 29% 41%
Price / Cash Flow Ratio 13.50 53% 28%
Price/Free Cash Flow Ratio 14.93 50% 25%
Management Effectiveness  
Return on Equity 7.62% 73% 48%
Return on Invested Capital 9.00% 93% 62%
Return on Assets 3.46% 67% 60%
Debt to Equity Ratio 141.19% 20% 23%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.